Great to see the team Memorial Sloan Kettering Cancer Center building on the CALGB 80803 PET-directed therapy trial with the addition of immunotherapy. Another promising development in the fight against cancer 🎉

Thanks to everyone that voted! We are pleased to announce that our next book is This Living and Immortal Thing by Austin Duffy Date TBC everyone very welcome. Please share!

Mark Lewis, MD, FASCO Catherine O’Connor Mike Pishvaian Johnathan Ebben MD, PhD Fergus Keane Wungki Park, MD MS Eileen M O’Reilly PanCAN Let's Win Pancreatic Cancer 💜 Pamela Kunz, MD, FASCO Shaalan Beg MD MBA FASCO @AaronGoodman33 Aparna Raj Parikh Benjamin Weinberg, MD, FACP A pancreatic cancer doctor Carla Cavalcanti Dr. Cathy Eng Jéssica Zanotti Felipe D'Almeida Flavio G Rocha, MD, FACS, FSSO Sakti Chakrabarti, MD Laura Goff Dr. jordan berlin Aman Chauhan Rachael Guenter Ryan Huey, MD, MS 🌟Distinguishing midgut from pancreatic #NETs can be perplexing. 😎Help spread the word to join Mark Lewis, MD, FASCO Catherine O’Connor on 07/25/23, 8 pm ET, as they shed light on it during #TumorBoardTuesday! 🌞Earn free CME credits integrityce.com/TBT2023 #PancCan

🇮🇪Case prep is underway for this week’s #TumorBoardTuesday! 👨🏻‍⚕️Join Wungki Park, MD MS Fergus Keane 08.29.23 8pm ET, to discuss utilizing Claudin 18.2 in #PancreaticCancer 🇮🇪Mark your calendar! 🧠Grab FREE #CME 👉🏽integrityce.com/TBT2023 for info #OncTwitter #PanCan

NOW OF: A US single-arm, single-centre, ph 2 trial assesses the safety and activity of regorafenib in combination with nivolumab and chemotherapy in the first-line treatment of advanced oesophagogastric adenocarcinoma. #gicsm thelancet.com/journals/lanon…

Congratulations Geraldine O'Sullivan Coyne and team Atezolizumab for Advanced Alveolar Soft Part Sarcoma | NEJM nejm.org/doi/full/10.10…

🪚CLAUDIN 18.2 has been a topic of discussion, & there’s fresh & emerging treatments for #GastricCancer 🇮🇪Join Sam Klempner Darren Cowzer on #TumorBoardTuesday Sept 26 to explore further 🌍Dive into this global discussion at 8pm EDT / 1am IST FREE #CME👉🏽integrityce.com/TBT2023

🌍 <1 hour until TONIGHT’S cross-continental #TumorBoardTuesday 🪚Sam Klempner Darren Cowzer join to cut deep into #GastricCancer + CLAUDIN 18.2 🪵Brush off the sawdust, throw on the oil, & grab a Guinness while you check out these #CME 👇🏽See y’all soon x.com/TumorBoardTues…

Proud to see this in print. Only possible with the brilliant mentorship of James J. Harding, MD and support of all STGI team MSK Department of Medicine Yelena Y. Janjigian MD Ghassan Abou-Alfa Eileen M O’Reilly & Co JCO Precision Oncology

First-line regorafenib with nivo & FOLFOX in GEJ/GC in the USA: a single-arm, single-centre, phase 2 trial The Lancet Oncology doi.org/10.1016/S1470-… 👉ORR: 76%, mPFS: 13mo, mOS: nr., regardless of PD-L1 CPS status 👉Efficacy, but also toxicity... 🧐Looks promising, ph-3 planned

👀 Check out what’s popular this week in #JCOPO: Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced #HepatocellularCarcinoma ➡️ brnw.ch/21wDi3w Darren Cowzer James J. Harding, MD #cfDNA #NGS

Excited to share our latest work in Journal for ImmunoTherapy of Cancer! David Faleck Steve Maron Darren Cowzer Yelena Y. Janjigian MD Memorial Sloan Kettering Cancer Center MSK Department of Medicine

🩸Data from Darren Cowzer, James J. Harding, MD, et al. showing how NGS of #cfDNA in HCC represents an alternative to tissue-based profiling given the high tumor-plasma NGS concordance. ➡️ brnw.ch/21wE02v #gicsm

Great to have mentors and colleagues @ImaneDika Geoff Ku from MSK Department of Medicine here presenting in Ireland CancerGathering

It was clear to see the enormous impact of Pat Smullen's legacy at The Curragh Racecourse this Saturday. The funds raised by Pat's family, friends, and the horse racing community since 2019 have made new clinical trials and treatment options for patients with #PancreaticCancer possible.

Featured today by MSK Library: A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier #study #tumors #hiddengenomeclassifier Thomas Boerner, MD, MSc Esther Drill cssigel Andrea Cercek Ghassan Abou-Alfa Chris Iacobuzio Darren Cowzer Henry Walch

Delighted to announce Goodman Fellowship opportunity in Phase 1 Oncology for medical oncology trainees in Ireland Mater Hospital Advanced Cancer Care. DM us here STARTDublin if interested

Featured today by MSK Library: Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy #Clinicogenomics #HepatocellularCarcinoma #Immunotherapy #CancerResearch #PredictiveBiomarkers #PrecisionMedicine #CancerOutcomes #Oncology

Starting at 11:30 a.m. PST: ASCO #GI25 poster sessions! Stop by the West Hall for #pancreaticcancer and #biliarytractcancer advances by James J. Harding, MD, Eileen M O’Reilly, Rohit Thummalapalli, Layal Al Mahmasani, and more! @mskcancercenter bit.ly/3WB5q7J

This retrospective study provides a comprehensive analysis of the clinical and genomic predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma. @cowzerdarren doi.org/10.1093/oncolo…